Repurposed Therapeutics, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray

Phase 2

Terminated

Conditions: Motion Sickness

Interventions: Drug: Scopolamine
Drug: Placebo

First Posted Date: 2014-06-04

Last Posted Date: 2018-01-17

Lead Sponsor: Repurposed Therapeutics, Inc.

Target Recruit Count: 63

Registration Number: NCT02155309

Locations: 🇺🇸
Naval Medical Research Unit, Dayton, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy